Tandem Diabetes Care Inc (STU:TD5A)
€ 29.15 -1.65 (-5.36%) Market Cap: 1.92 Bil Enterprise Value: 1.92 Bil PE Ratio: 0 PB Ratio: 8.66 GF Score: 82/100

Tandem Diabetes Care Inc at Barclays Global Healthcare Conference Transcript

Mar 11, 2020 / 06:05PM GMT
Release Date Price: €62.19 (+2.39%)
Kristen Marie Stewart
Barclays Bank PLC, Research Division - Research Analyst

Good afternoon, and thank you for joining us here at the Barclays Global Health Care Conference in virtual form. I am Kristen Stewart, the medical supplies and devices analyst. And it is my pleasure to be hosting Tandem Diabetes Care this afternoon.

I have with us today, John Sheridan, the company's President and CEO. We also have with us Leigh Vosseller, the Chief Financial Officer; as well as Susan Morrison, the Chief Administrative Officer.

Questions & Answers

Kristen Marie Stewart
Barclays Bank PLC, Research Division - Research Analyst

Going to kick it off with probably the topic that everyone's talking about and wondering about, which is the coronavirus. I was wondering if you guys could just maybe share with us your perspectives on what the current COVID-19 situation means for Tandem. It's obviously a very fluid and dynamic situation. I know you manufacture products in San Diego, but I believe, you use a small number of suppliers for components. Some of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot